TBCEL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.192500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.809000E-01
Normal-vs-Stage2
8.447700E-02
Normal-vs-Stage3
1.181800E-01
Normal-vs-Stage4
4.010600E-01
Stage1-vs-Stage2
2.807200E-01
Stage1-vs-Stage3
5.124300E-02
Stage1-vs-Stage4
8.756600E-01
Stage2-vs-Stage3
3.358100E-03
Stage2-vs-Stage4
4.900200E-01
Stage3-vs-Stage4
5.369800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.577500E-02
Normal-vs-AfricanAmerican
6.005600E-01
Normal-vs-Asian
4.232300E-02
Caucasian-vs-AfricanAmerican
1.489000E-01
Caucasian-vs-Asian
2.451800E-01
AfricanAmerican-vs-Asian
6.056300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.485900E-02
Normal-vs-Female
1.338590E-01
Male-vs-Female
1.737960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.031800E-01
Normal-vs-Age(41-60Yrs)
2.638000E-01
Normal-vs-Age(61-80Yrs)
6.015500E-02
Normal-vs-Age(81-100Yrs)
2.996000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.932200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.437400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.426800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.114020E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.470200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.294300E-02
Normal-vs-Daily Drinker
3.342600E-03
Normal-vs-Weekly Drinker
7.103600E-02
Normal-vs-Occasional Drinker
2.498800E-01
Normal-vs-Social Drinker
5.139000E-01
Non Drinker-vs-Daily Drinker
3.452200E-01
Non Drinker-vs-Weekly Drinker
7.795600E-01
Non Drinker-vs-Occasional Drinker
1.666050E-01
Non Drinker-vs-Social Drinker
8.278400E-02
Daily Drinker-vs-Weekly Drinker
2.879800E-01
Daily Drinker-vs-Occasional Drinker
5.426100E-02
Daily Drinker-vs-Social Drinker
2.685800E-02
Weekly Drinker-vs-Occasional Drinker
3.892000E-01
Weekly Drinker-vs-Social Drinker
1.641620E-01
Occasional Drinker-vs-Social Drinker
5.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.537400E-01
Normal-vs-Grade 2
1.558360E-01
Normal-vs-Grade 3
1.174380E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.228400E-01
Grade 1-vs-Grade 3
8.086000E-01
Grade 1-vs-Grade 4
2.537400E-01
Grade 2-vs-Grade 3
8.317200E-01
Grade 2-vs-Grade 4
1.558360E-01
Grade 3-vs-Grade 4
1.174380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.070100E-02
Normal-vs-NonDiabetic
6.412400E-02
Diabetic-vs-NonDiabetic
5.091800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.277790E-02
Normal-vs-NoPancreatitis
6.894300E-02
Pancreatitis-vs-NoPancreatitis
3.306600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.595440E-01
Normal-vs-N1
7.612300E-02
N0-vs-N1
9.838200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.532200E-02
Normal-vs-TP53-NonMutant
2.867400E-01
TP53-Mutant-vs-TP53-NonMutant
1.749420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
